An approved treatment as an adjunct to diet and other low-density lipoprotein-cholesterol (LDL-C) lowering therapies for the treatment of adult and paediatric patients aged 6 months and older with homozygous familial hypercholesterolaemia (HoFH).
- Procurement
- Evinacumab
- Published
- 13 May 2026
- Status
- complete
- CPV
- —
- Tender period
- —
Other notices in this procurement
FAQs about this notice
What type of notice is this?
This is a award,contract published via Find a Tender on 13 May 2026.
Which procurement does this notice belong to?
It is part of "Evinacumab", published by Southern Health and Social Care Trust.
Get the full procurement picture
Enable turns the UK's public-contract data into pipeline intelligence for bid and capture teams. Talk to us about access, alerts and tailored market analysis.
Get in touch with Enable